Our Science – Lazarevic Website
Vanja Lazarevic, Ph.D.
Selected Publications |
 |
| 1)
Wein MN, Jones DC, Shim JH, Aliprantis AO, Sulyanto R, Lazarevic V, Poliachik SL, Gross TS, Glimcher LH. Control of bone resorption in mice by Schnurri-3. Proc. Natl. Acad. Sci. U.S.A. 109: 8173-8, 2012. [Journal] |
|
| 2)
Staton TL, Lazarevic V, Jones DC, Lanser AJ, Takagi T, Ishii S, Glimcher LH. Dampening of death pathways by schnurri-2 is essential for T-cell development. Nature. 472: 105-9, 2011. [Journal] |
|
| 3)
Lazarevic V, Glimcher LH. T-bet in disease. Nat. Immunol. 12: 597-606, 2011. [Journal] |
|
| 4)
Lazarevic V, Chen X, Shim J, Hwang E, Jang E, Bolm AN, Oukka M, Kuchroo VK, Glimcher LH. T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORgammat. Nat. Immunol. 12: 96-104, 2011. [Journal] |
|
| 5)
Riol-Blanco L, Lazarevic V, Awasthi A, Mitsdoerffer M, Wilson BS, Croxford A, Waisman A, Kuchroo VK, Glimcher LH, Oukka M. IL-23 receptor regulates unconventional IL-17-producing T cells that control bacterial infections. J. Immunol. 184: 1710-20, 2010. [Journal] |
|
| 6)
Lazarevic V, Zullo AJ, Schweitzer MN, Staton TL, Gallo EM, Crabtree GR, Glimcher LH. The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells. Nat. Immunol. 10: 306-13, 2009. [Journal] |
|
| 7)
Lazarevic V, Martinon F. Linking inflammasome activation and phagosome maturation. Cell Host Microbe. 3: 199-200, 2008. [Journal] |
|
| 8)
Deslouches B, Phadke SM, Lazarevic V, Cascio M, Islam K, Montelaro RC, Mietzner TA. De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity. Antimicrob. Agents Chemother. 49: 316-22, 2005. [Journal] |
|
| 9)
Sullivan BM, Jobe O, Lazarevic V, Vasquez K, Bronson R, Glimcher LH, Kramnik I. Increased susceptibility of mice lacking T-bet to infection with Mycobacterium tuberculosis correlates with increased IL-10 and decreased IFN-gamma production. J. Immunol. 175: 4593-602, 2005. [Journal] |
|
| 10)
Lazarevic V, Yankura DJ, DiVito SJ, Flynn JL. Induction of Mycobacterium tuberculosis-specific primary and secondary T-cell responses in interleukin-15-deficient mice. Infect. Immun. 73: 2910-22, 2005. [Journal] |
|
| 11)
Lazarevic V, Nolt D, Flynn JL. Long-term control of Mycobacterium tuberculosis infection is mediated by dynamic immune responses. J. Immunol. 175: 1107-17, 2005. [Journal] |
|
| 12)
Lazarevic V, Myers AJ, Scanga CA, Flynn JL. CD40, but not CD40L, is required for the optimal priming of T cells and control of aerosol M. tuberculosis infection. Immunity. 19: 823-35, 2003. [Journal] |
|
| 13)
Lazarevic V, Flynn J. CD8+ T cells in tuberculosis. Am. J. Respir. Crit. Care Med. 166: 1116-21, 2002. [Journal] |
|
| 14)
Phadke SM, Lazarevic V, Bahr CC, Islam K, Stolz DB, Watkins S, Tencza SB, Vogel HJ, Montelaro RC, Mietzner TA. Lentivirus lytic peptide 1 perturbs both outer and inner membranes of Serratia marcescens. Antimicrob. Agents Chemother. 46: 2041-5, 2002. [Journal] |
|
| 15)
Serbina NV, Lazarevic V, Flynn JL. CD4(+) T cells are required for the development of cytotoxic CD8(+) T cells during Mycobacterium tuberculosis infection. J. Immunol. 167: 6991-7000, 2001. [Journal] |
|
| Click Here to View Collapsed Bibliography. |
This page was last updated on 1/16/2013.
